A Study of Tivozanib in Combination With Durvalumab in Subjects With Untreated Advanced Hepatocellular Carcinoma

No author metadata is attached to this paper.

Published 2019 in Case Medical Research

ABSTRACT

No abstract is available for this paper.

PUBLICATION RECORD

Publication year
2019
Venue
Case Medical Research
Publication date
2019-05-31
Fields of study
Not labeled
Identifiers
DOI 10.31525/ct1-nct03970616
External record
Open on Semantic Scholar
Source metadata
Semantic Scholar

CITATION MAP

EXTRACTION MAP

CLAIMS

No claims are published for this paper.

CONCEPTS

No concepts are published for this paper.

REFERENCES

No references are available for this paper.

CITED BY

Immunotherapy for Hepatocellular Carcinoma: A 2021 Update
2020cites this paper
The Current Landscape of Immune Checkpoint Blockade in Hepatocellular Carcinoma: A Review.
2020cites this paper